The Readout

The Readout February 6, 2025

AstraZeneca offers some reassurance on China challenges 

Adam's Take

Adam's Take February 6, 2025

STAT Plus: Previewing Immunovant’s myasthenia gravis study readout — with all its quirky nuance

advertisement

Special Report

Special Report February 6, 2025

STAT Plus: The CRISPR companies are not OK

The Readout

The Readout February 5, 2025

This week in biotech earnings so far

Biotech

Biotech February 4, 2025

STAT Plus: Study of Amgen’s early obesity candidate paused by FDA